Updates in Lymphoma

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes

Overview

This course is designed to explore the multifaceted landscape of mature non-Hodgkin B-cell lymphomas, including their pathogenesis, risks, initial presentation, and advanced treatment options. Furthermore, the course will delve into collaborative strategies, with a focus on mitigating disparities of care, for managing treatment- and disease-related side effects commonly associated with B-cell malignancies.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Discuss the pathogenesis, risks, and initial presentation of mature non-Hodgkin B-cell lymphomas and closely related disease
  2. Identify treatment options for mature non-Hodgkin B-cell lymphomas based on patient and mutational factors
  3. Describe collaborative strategies, including those to mitigate disparities of care, to the management of treatment- and disease-related side effects typically associated with the  care of patients with B-cell malignancies 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
01/19/2024
Course expires: 
01/19/2025
Cost:
$0.00
Rating: 
0

Faculty

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Laura J. Zitella is a Hematology Nurse Practitioner in the Hematology, Blood, Marrow Transplant, and Cellular Therapy (HBC) Program at UCSF Health and is an Associate Clinical Professor in the Department of Physiological Nursing at the University of California San Francisco. She earned her Master of Science from the University of Illinois in Chicago. Laura holds certifications as an Acute Care Nurse Practitioner and an Advanced Oncology Certified Nurse. With more than 25 years of experience in oncology practice, Ms. Zitella is recognized as a national nurse practitioner leader. Her clinical expertise includes patients with hematologic malignancies receiving chemotherapy, immunotherapy, targeted therapy, investigational agents, hematopoietic cell transplantation, cellular therapy, and supportive care. 

She is a prominent educator who has delivered hundreds of educational presentations to national and international audiences and authored numerous peer-reviewed publications, web courses, videos, and book chapters. She is a member of the Advanced Practitioner Society of Hematology and Oncology (APSHO), the Advanced Practice Provider Oncology Summit Planning Committee, the Association of Community Cancer Centers (ACCC), the California Association of Nurse Practitioners (CANP), the Oncology Nursing Society (ONS), the Society of Hematologic Oncology (SOHO), and the Society for Immunotherapy of Cancer (SITC).

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Laura J Zitella, MS, RN, ACNP-BC, AOCN discloses Speaker's Bureau with Abbvie but this relationship has ended during the past 24 months.

Available Credit

  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above